The central nervous system can respond to threat via the induction of an inflammatory
response. Under normal circumstances this response is tightly controlled, however …

In recent years, microRNAs (miRNAs) have gained increased attention from researchers
around the globe. Although it is twenty nucleotides long, it can modulate several gene …

Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system (CNS). There is currently no single definitive test for MS. Circulating …

Multiple sclerosis (MS) is a chronic neurodegenerative autoimmune disease with a complex
clinical course characterized by inflammation, demyelination, and axonal degeneration …

Multiple sclerosis (MS) is an autoimmune pathology leading to neurodegeneration. Because
of the complexity and heterogenic etiology of this disease, diagnosis and treatment for …

Multiple sclerosis (MS) is a chronic progressive inflammatory disease of the central nervous
system (CNS) that leads to severe neurological disability. There is an interest in potential …

B cells mediate multiple sclerosis (MS) pathogenesis by mechanisms unrelated to
immunoglobulin (Ig). We reported that supernatants (Sup) from cultured B cells from blood of …

Cancer remains one of the most threatening causes of human health impairment, and the
mechanisms underlying tumorigenesis have not been completely characterized. MicroRNAs …

In the current study, we aimed to identify nanocurcumin effects on microRNAs (miRNAs) in
the peripheral blood of patients with relapsing‐remitting multiple sclerosis (RRMS). We …

Objective To identify circulating microRNAs (miRNAs) linked to disease, disease stage, and
disability in MS across cohorts. Methods Samples were obtained from the Comprehensive …